[Fabry disease]

Przegl Lek. 2006;63(4):218-9.
[Article in Polish]

Abstract

Fabry disease is a rare genetic disorder, which is linked to a defect of alfa-galactosidase. In consequence it leads to an excess of glicosphyngolipids in lysosomes of various tissues and organs. Clinical symptoms are related to heart, skin, kidneys and nervous system. Nowadays due to a possibility of substitution of galactosidase A, a influence on clinical course of the disease can be attained: arresting of progression and avoidance of complications.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Disease Progression
  • Fabry Disease / diagnosis
  • Fabry Disease / genetics
  • Fabry Disease / physiopathology*
  • Fabry Disease / therapy
  • Female
  • Genetic Therapy
  • Humans
  • Isoenzymes / genetics
  • Isoenzymes / therapeutic use
  • Kidney / metabolism
  • Lysosomes / metabolism
  • Male
  • Rare Diseases / metabolism
  • Skin / metabolism
  • Trihexosylceramides / metabolism*
  • alpha-Galactosidase / genetics*
  • alpha-Galactosidase / therapeutic use*

Substances

  • Isoenzymes
  • Trihexosylceramides
  • alpha-Galactosidase